CAP TODAY/Agendia Webinar: Expanding the Clinical Utility of Genomic Profiling in Early-Stage Breast Cancer

Thank you

This live web event has ended. Thank you for attending.

Description

Expanding the Clinical Utility
of Genomic Profiling in
Early-Stage Breast Cancer

Why should you register now for this webinar?
Hear leading experts discuss genomic testing to support treatment planning
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenters: William Audeh, MD, and Hannah Gilmore, MD

What will this webinar empower you to do?

Understand data supporting pre- and post-operative treatment planning using MammaPrint^® and BluePrint^®
Review the latest MammaPrint and BluePrint data presented at SABCS 2021
Appreciate the real-world impact of MammaPrint and BluePrint at the University Hospitals Cleveland Medical Center
Ask questions of our distinguished presenters

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from Agendia.

Contributors

William Audeh, MD

Chief Medical Officer, Agendia
Medical oncologist specializing in breast cancer, with nearly 30 years of experience as a clinician and clinical researcher at the Cedars-Sinai Cancer Center in Los Angeles. Prior to joining Agendia, and in addition to his clinical practice, he served as the former Director of the Cedars-Sinai Cancer Center and Medical Director of the Wasserman Breast Cancer Risk Reduction Program. Dr. Audeh has been Principal Investigator on a wide variety of national and international clinical and translational trials, and has authored numerous publications in the field of breast cancer, cancer genomics and targeted cancer therapy.
Hannah Gilmore, MD

Division Chief, Anatomic Pathology
Director of Breast Pathology
University Hospitals Cleveland Medical Center, Cleveland, OH
Bob McGonnagle

Publisher, CAP TODAY